A sticky story for signal transducer and activator of transcription 3 in platelets

Circulation

Volumn 127, Issue 4, 2013, Pages 422-423

  Chen, Karin ^a   Rondina, Matthew T ^a   Weyrich, Andrew S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Editorials; Inflammation; Platelets; Thrombosis; Transcription factors

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM; CD36 ANTIGEN; CELL NUCLEUS DNA; COLLAGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PADGEM PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN INHIBITOR; STAT3 PROTEIN; STAT3 PROTEIN INHIBITOR; THROMBIN RECEPTOR; TOCILIZUMAB; UNCLASSIFIED DRUG; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE;

ANGIOGENESIS; APOPTOSIS; ATTENUATION; BLOOD FLOW; CALCIUM TRANSPORT; CELL CYCLE REGULATION; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOPLASM; EDITORIAL; EXTRACELLULAR MATRIX; HUMAN; MEDIATOR; MITOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBUS; ANIMAL; METABOLISM; NOTE; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULITIS;

ANIMALS; HUMANS; PLATELET AGGREGATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VASCULITIS;

EID: 84873186878     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.155366     Document Type: Editorial

References (18)

1. Reich NC, Liu L. Tracking STAT nuclear traffic. Nat Rev Immunol. 2006;6:602-612. (Pubitemid 44134093)
2. Yue P, Turkson J. Targeting STAT3 in cancer: how successful are we? Expert Opin Investig Drugs. 2009;18:45-56.
3. Drachman JG, Sabath DF, Fox NE, Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood. 1997;89:483-492. (Pubitemid 27051683)
4. Tibbles HE, Vassilev A, Wendorf H, Schonhoff D, Zhu D, Lorenz D, Waurzyniak B, Liu XP, Uckun FM. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation. J Biol Chem. 2001;276:17815-17822.
5. Zhou Z, Gushiken FC, Bolgiano D, Salsbery BJ, Aghakasiri N, Jing N, Wu X, Vijayan KV, Rumbaut RE, Adachi R, Lopez JA, Dong JF. Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity. Circulation. 2013;127:476-485.
6. Spinelli SL, Maggirwar SB, Blumberg N, Phipps RP. Nuclear emancipation: a platelet tour de force. Sci Signal. 2010;3:e37.
7. Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA. 1998;95:5556-5561. (Pubitemid 28224133)
8. Gambaryan S, Kobsar A, Rukoyatkina N, Herterich S, Geiger J, Smolenski A, Lohmann SM, Walter U. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J Biol Chem. 2010;285:18352-18363.
9. Spinelli SL, Casey AE, Pollock SJ, Gertz JM, McMillan DH, Narasipura SD, Mody NA, King MR, Maggirwar SB, Francis CW, Taubman MB, Blumberg N, Phipps RP. Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler Thromb Vasc Biol. 2010;30:591-598.
10. Moraes LA, Spyridon M, Kaiser WJ, Jones CI, Sage T, Atherton RE, Gibbins JM. Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation. J Thromb Haemost. 2010;8:577-587.
11. Moraes LA, Swales KE, Wray JA, Damazo A, Gibbins JM, Warner TD, Bishop-Bailey D. Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets. Blood. 2007;109:3741-3744. (Pubitemid 46641723)
12. Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci. 2012;122:143-159
13. Rose-John S, Neurath MF. IL-6 trans-signaling: the heat is on. Immunity. 2004;20:2-4. (Pubitemid 38134288)
14. Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J Immunol. 2006;176:1978-1987. (Pubitemid 43134344)
15. Sansone P, Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol. 2012;30:1005-1014.
16. Atzeni F, Benucci M, Salli S, Bongiovanni S, Boccassini L, Sarzi-Puttini P. Different effects of biological drugs in rheumatoid arthritis. Autoimmun Rev. December 3, 2012. doi:pii: S1568-9972 (12) 00278-9. 10.1016/j. autrev. 2012.10.020. http://www.journals.elsevier.com/autoimmunityreviews. Accessed January 8, 2013.
17. Lim CP, Fu XY. Multiple roles of STAT3 in cardiovascular inflammatory responses. Prog Mol Biol Transl Sci. 2012;106:63-73.
18. Yeung J, Holinstat M. Newer agents in antiplatelet therapy: a review. J Blood Med. 2012;3:33-42.